In brief
16th Nov 2006, 14:31 GMT
Shanghai BoundNovartis says it will build a $100-million research centre in Shanghai, specializing in infectious causes of cancer. The lab will start operations next May in temporary premises and then build a larger facility, which, the Swiss drug company says, will eventually house 400